Cancer Research Meeting Calendar  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 1980-1986, April 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Salewski, H.
Right arrow Articles by Scheidtmann, K. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Salewski, H.
Right arrow Articles by Scheidtmann, K. H.
[Cancer Research 59, 1980-1986, April 15, 1999]
© 1999 American Association for Cancer Research


Molecular Biology and Genetics

Increased Oncogenicity of Subclones of SV40 Large T-induced Neuroectodermal Tumor Cell Lines after Loss of Large T Expression and Concomitant Mutation in p531

Holger Salewski, Thomas A. Bayer, Ulf Eidhoff2, Ute Preuss, Sascha Weggen and Karl Heinz Scheidtmann3

Institut für Genetik der Universität Bonn, D-53117 Bonn [H.S., U.E., U.P., K.H.S.]; and Institut für Neuropathologie [T. A. B., S. W.] and Klinik für Psychiatrie [T. A. B.], Medizinische Einrichtungen der Universität Bonn, D-53105 Bonn, Germany

A model for medulloblastoma-like primitive neuroectodermal tumors was established in rat using retrovirally transduced SV40 large T antigen (LT) as an inducing agent (O. D. Wiestler et al., Brain Pathol., 2: 47–59, 1992). A cell line isolated from such a tumor and clonal derivatives thereof were biologically and molecularly characterized. In the parental tumor cell line, TZ870, which had been selected for G418 resistance, virtually all cells expressed LT and wild-type p53, which were complexed to each other. When plated in soft agar, these cells grew relatively slowly and formed disperse colonies. However, when grown without selection pressure, these cells reproducibly gave rise to LT-negative and G418-sensitive derivatives, LT-0 cells. Surprisingly, these latter cells exhibited a higher degree of malignancy both in vitro, growing readily to large colonies in soft agar, and in vivo, where they gave rise to a rapidly growing malignant tumor. Clonal selection from TZ870 cells revealed two types of clones: in one type, LT expression was stably maintained, even without selection pressure, whereas the other type lost the LT coding sequences. All LT-negative clones exhibited the same phenotype as the LT-0 cells. Reexpression of LT had no effect. However, LT no longer formed complexes with p53, and p53 was metabolically stable, suggesting that it had been mutated. Sequence analyses and diagnostic restriction digests of the p53 gene revealed that (a) both the parental LT-transformed cells and their derivatives contained only one complete p53 allele and (b) all LT-positive clones expressed wild-type p53, whereas all LT-negative clones expressed a mutant allele with a common mutation at Cys-174->Tyr, indicating their clonal origin. We assume that the loss of LT coding sequences is the consequence of the p53 mutation, perhaps by inducing genomic instability, and that both the p53 mutation and additional genetic alterations that accompany the loss of LT coding sequences might contribute to enhanced malignancy.




This article has been cited by other articles:


Home page
Cancer Res.Home page
J. J. Manfredi, J. Dong, W.-j. Liu, L. Resnick-Silverman, R. Qiao, P. Chahinian, M. Saric, A. R. Gibbs, J. I. Phillips, J. Murray, et al.
Evidence against a Role for SV40 in Human Mesothelioma
Cancer Res., April 1, 2005; 65(7): 2602 - 2609.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. S. Butel
Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease
Carcinogenesis, March 1, 2000; 21(3): 405 - 426.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. Rizzo, M. Carbone, S. G. Fisher, C. Matker, L. J. Swinnen, A. Powers, I. Di Resta, S. Alkan, H. I. Pass, and R. I. Fisher
Simian Virus 40 Is Present in Most United States Human Mesotheliomas, but It Is Rarely Present in Non-Hodgkin’s Lymphoma*
Chest, December 1, 1999; 116 (2009): 470S - 473S.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. S. Butel and J. A. Lednicky
RESPONSE: Re: Cell and Molecular Biology of Simian Virus 40: Implications for Human Infections and Disease
J Natl Cancer Inst, July 7, 1999; 91(13): 1166a - 1167a.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.